Randomised clinical trial to determine the incidence of Cystoid Macular Oedema (CMO) after cataract surgery with Intraocular Cefuroxime.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13489716

Enrollment

120

Registered

2004-09-30

Start date

2003-09-19

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery: Cataract Surgery Cataract

Interventions

120 patients, aged above 50 years having cataract surgery, 60 of which will receive intraocular cefuroxime, and 60 of which will not receive intraocular cefuroxime.

Eligibility

Inclusion criteria

Inclusion criteria: 120 patients, aged above 50 years having cataract surgery.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026